InvestorsHub Logo
Followers 58
Posts 10136
Boards Moderated 1
Alias Born 09/21/2016

Re: bas2020 post# 413450

Tuesday, 05/02/2023 10:30:18 AM

Tuesday, May 02, 2023 10:30:18 AM

Post# of 461882
bas2020...

Let's review, again, the results of the "P3" AD trial...

1. All endpoints met: ADAS-Cog, ADCS-ADL and CDR-SB.

2. Odds Ratios highlighting the Super Responders for both Cog and ADL.

KEM and subgroup analysis, MRI results and Study data are forthcoming to detail the efficacy aspects and demonstrate additional benefits in the study.

It's that simple.



YUP, or , we can just drag this on until someone finally buries us w/piles of strong RWE-RWD and happy RSD kids signing in a choir....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News